documents: FDA-2024-N-1636-0002

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2024-N-1636-0002 FDA FDA-2024-N-1636 Issuance of Priority Review Voucher; Rare Pediatric Disease Product; KEBILIDI (eladocagene exuparvovectneq) Notice Announcement 2024-12-02T05:00:00Z 2024 12 2024-12-02T05:00:00Z   2024-12-02T15:11:50Z 2024-28206 0 0 0900006486843d8e

Links from other tables